Inspire Advisors, LLC Syndax Pharmaceuticals Inc Transaction History

Inspire Advisors, LLC

  • $721 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023
SELL
$14.52 - $21.77 $300,868 - $451,096
-20,721 Reduced 50.19%
20,561 $298,000
Q2 2023

Jul 31, 2023
BUY
$19.35 - $22.31 $109,946 - $126,765
5,682 Added 15.96%
41,282 $864,000
Q1 2023

Apr 24, 2023
BUY
$20.66 - $28.98 $735,496 - $1.03 Million
35,600 New
35,600 $751,000

Others Institutions Holding SNDX

# of Institutions
227
Shares Held
95.1M
Call Options Held
759K
Put Options Held
635K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $844M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email